Flutterby™! : Statin use and COVID-19 mortality 2021-03-06 17:59:05.607042+01

Statin use and COVID-19 mortality

2021-03-06 17:59:05.607042+01 by Dan Lyke 0 comments

Interesting: Statin users 50% less likely to die in hospital from severe COVID-19

Nature Communications: Association between antecedent statin use and decreased mortality in hospitalized patients with COVID-19

... The primary endpoint includes in-hospital mortality within 30 days. A total of 2626 patients were admitted during the study period, of whom 951 (36.2%) were antecedent statin users. Among 1296 patients (648 statin users, 648 non-statin users) identified with 1:1 propensity-score matching, statin use is significantly associated with lower odds of the primary endpoint in the propensity-matched cohort (OR 0.47, 95% CI 0.36–0.62, p < 0.001). We conclude that antecedent statin use in patients hospitalized with COVID-19 is associated with lower inpatient mortality.

https://doi.org/10.1038/s41467-021-21553-1

Comment policy

We will not edit your comments. However, we may delete your comments, or cause them to be hidden behind another link, if we feel they detract from the conversation. Commercial plugs are fine, if they are relevant to the conversation, and if you don't try to pretend to be a consumer. Annoying endorsements will be deleted if you're lucky, if you're not a whole bunch of people smarter and more articulate than you will ridicule you, and we will leave such ridicule in place.

Flutterby™ is a trademark claimed by